Nora Signs an Exclusive Agreement Biopharmaceutical Partner to Launch a Biosimilar in Canada

Shots:

• Nora collaborates with a biopharmaceutical partner to obtain the commercial rights for a biosimilar drug
• The collaboration will support both private insurers and public formularies by reducing the costs of biosimilars & provide accessibility to patients for high quality affordable pharmaceutical products
• Nora Pharma’s activities coordinate with the biosimilars transition policy adopted by several Canadian provinces

Click here to­ read full press release/ article | Ref: Newswire | Image: Stat News